Adamis Pharmaceuticals reported 4.6M in Trade Debtors for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Adamis Pharmaceuticals ADMP:US 4.6M 1.3M
Adma Biologics ADMA:US $ 25.63M 2.95M
Brainstorm Cell Therapeutics BCLI:US $ 61K 25K
Cara Therapeutics CARA:US $ 3.63M 2.48M
Cerulean Pharma CERU:US $ 1.73M 584.53K
Glaxosmithkline GSK:US $ 6870M 1927M
GlaxoSmithKline GSK:LN 6.87B 1.93B
Redhill Biopharma RDHL:US $ 25.93M 5.74M